Northern Trust’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-797,888
| Closed | -$14.2M | – | 4335 |
|
|
2018
Q3 | $14.2M | Buy |
797,888
+15,441
| +2% | +$274K | ﹤0.01% | 2036 |
|
|
2018
Q2 | $10.8M | Buy |
782,447
+652,821
| +504% | +$9.01M | ﹤0.01% | 2224 |
|
|
2018
Q1 | $1.18M | Buy |
129,626
+48,770
| +60% | +$443K | ﹤0.01% | 3333 |
|
|
2017
Q4 | $346K | Buy |
80,856
+1,820
| +2% | +$7.79K | ﹤0.01% | 3644 |
|
|
2017
Q3 | $112K | Sell |
79,036
-3
| -0% | -$4 | ﹤0.01% | 3928 |
|
|
2017
Q2 | $119K | Sell |
79,039
-317,009
| -80% | -$477K | ﹤0.01% | 3933 |
|
|
2017
Q1 | $1.02M | Buy |
396,048
+1,278
| +0.3% | +$3.29K | ﹤0.01% | 3345 |
|
|
2016
Q4 | $1.01M | Buy |
394,770
+13,108
| +3% | +$33.4K | ﹤0.01% | 3347 |
|
|
2016
Q3 | $1.18M | Buy |
381,662
+1,603
| +0.4% | +$4.95K | ﹤0.01% | 3295 |
|
|
2016
Q2 | $1.22M | Buy |
380,059
+20,206
| +6% | +$64.9K | ﹤0.01% | 3285 |
|
|
2016
Q1 | $1.12M | Buy |
359,853
+1,598
| +0.4% | +$4.96K | ﹤0.01% | 3216 |
|
|
2015
Q4 | $1.44M | Sell |
358,255
-3,746
| -1% | -$15K | ﹤0.01% | 3193 |
|
|
2015
Q3 | $1.66M | Sell |
362,001
-51,046
| -12% | -$234K | ﹤0.01% | 3139 |
|
|
2015
Q2 | $2.14M | Buy |
413,047
+19,891
| +5% | +$103K | ﹤0.01% | 3021 |
|
|
2015
Q1 | $2.46M | Sell |
393,156
-1,538
| -0.4% | -$9.63K | ﹤0.01% | 3002 |
|
|
2014
Q4 | $2.48M | Sell |
394,694
-15,250
| -4% | -$95.9K | ﹤0.01% | 2960 |
|
|
2014
Q3 | $2.49M | Buy |
409,944
+5,847
| +1% | +$35.5K | ﹤0.01% | 2957 |
|
|
2014
Q2 | $2.66M | Sell |
404,097
-3,770
| -0.9% | -$24.8K | ﹤0.01% | 2907 |
|
|
2014
Q1 | $9.71M | Sell |
407,867
-34,318
| -8% | -$817K | ﹤0.01% | 2128 |
|
|
2013
Q4 | $4.72M | Buy |
442,185
+8,688
| +2% | +$92.8K | ﹤0.01% | 2611 |
|
|
2013
Q3 | $5.78M | Buy |
433,497
+15,124
| +4% | +$202K | ﹤0.01% | 2410 |
|
|
2013
Q2 | $5.49M | Buy |
+418,373
| New | +$5.49M | ﹤0.01% | 2337 |
|